{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:49:08Z","timestamp":1755218948911,"version":"3.43.0"},"reference-count":77,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206297","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T14:39:43Z","timestamp":1754491183000},"source":"Crossref","is-referenced-by-count":0,"title":["Age-related trends in amyloid positivity in Parkinson\u2019s disease without dementia"],"prefix":"10.18632","author":[{"given":"Keiko","family":"Hatano","sequence":"first","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kameyama","sequence":"additional","affiliation":[{"name":"AI and Theoretical Image Processing, Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"},{"name":"Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Ohse","sequence":"additional","affiliation":[{"name":"Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Higashihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renpei","family":"Sengoku","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nishina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutomi","family":"Kanemaru","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"},{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"},{"name":"Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"13","author":"Revesz","year":"2011","journal-title":"Brain"},{"key":"2","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of \u03b1-synuclein and A\u03b2 in Parkinson disease patients with dementia.","volume":"6","author":"Perlmutter","year":"2012","journal-title":"Arch Neurol"},{"key":"3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4172\/2161-0460.1000444","article-title":"The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.","volume":"8","author":"Hurtig","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3233\/JAD-190323","article-title":"Clinical Correlates of Cerebral Amyloid Deposition in Parkinson\u2019s Disease Dementia: Evidence from a PET Study.","volume":"7","author":"Ceravolo","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.","volume":"8","author":"Siderowf","year":"2019","journal-title":"Ann Neurol"},{"key":"6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative.","volume":"9","author":"Shaw","year":"2020","journal-title":"Multimodal"},{"key":"7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations Between Tau, \u03b2-Amyloid, and Cognition in Parkinson Disease.","volume":"7","author":"Jagust","year":"2018","journal-title":"JAMA Neurol"},{"key":"8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","article-title":"Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.","volume":"14","author":"Wolk","year":"2022","journal-title":"Acta Neuropathol"},{"key":"9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","article-title":"Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.","volume":"4","author":"Warner","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.","volume":"7","author":"Clark","year":"2010","journal-title":"Neurology"},{"key":"11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12031-015-0647-x","article-title":"CSF \u03b2-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease.","volume":"5","author":"Alcalay","year":"2016","journal-title":"J Mol Neurosci"},{"key":"12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study.","volume":"1","author":"Schott","year":"2017","journal-title":"Lancet Neurol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.","volume":"3","author":"Aarsland","year":"2016","journal-title":"Mov Disord"},{"key":"14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson\u2019s disease: Different sides of the same coin?","volume":"3","author":"Kordower","year":"2017","journal-title":"Mov Disord"},{"key":"15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.01.009","article-title":"Octogenarian parkinsonism - Clinicopathological observations.","volume":"3","author":"Rajput","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.parkreldis.2018.07.015","article-title":"Very old onset parkinsonism: A clinical-pathological study.","volume":"5","author":"Jellinger","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000464322","article-title":"Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson\u2019s Disease without Dementia.","volume":"7","author":"Nakahara","year":"2017","journal-title":"Eur Neurol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/diagnostics10121015","article-title":"A\/T\/(N) Profile in Cerebrospinal Fluid of Parkinson\u2019s Disease with\/without Cognitive Impairment and Dementia with Lewy Bodies.","volume":"1","author":"Parnetti","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease.","volume":"1","author":"Montine","year":"2018","journal-title":"Alzheimers Dement"},{"key":"20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/gps.4513","article-title":"Distribution of Mini-Mental State Examination scores among urban community-dwelling older adults in Japan.","volume":"3","author":"Awata","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"21","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1212\/WNL.0000000000002461","article-title":"Age at onset and Parkinson disease phenotype.","volume":"8","author":"Pavese","year":"2016","journal-title":"Neurology"},{"key":"22","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1212\/WNL.0000000000006737","article-title":"Age and time course of long-term motor and nonmotor complications in Parkinson disease.","volume":"9","author":"Thobois","year":"2019","journal-title":"Neurology"},{"key":"23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaneurol.2017.3029","article-title":"Amyloid \u03b2 Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.","volume":"7","author":"Snitz","year":"2018","journal-title":"JAMA Neurol"},{"key":"24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-018-0459-7","article-title":"Prevalence and risk of progression of preclinical Alzheimer\u2019s disease stages: a systematic review and meta-analysis.","volume":"1","author":"Eusebi","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"25","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.","volume":"31","author":"Arnold","year":"2015","journal-title":"JAMA"},{"key":"26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jalz.2018.03.009","article-title":"Japanese and North American Alzheimer\u2019s Disease Neuroimaging Initiative studies: Harmonization for international trials.","volume":"1","author":"Beckett","year":"2018","journal-title":"Alzheimers Dement"},{"key":"27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.3885","article-title":"Inhibition of amyloid-\u03b2 plaque formation by \u03b1-synuclein.","volume":"2","author":"Hyman","year":"2015","journal-title":"Nat Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.","volume":"3","author":"Masliah","year":"2008","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (A\u03b2) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with A\u03b2 Pathology.","volume":"10","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/acs.biochem.9b00655","article-title":"Interactions between Soluble Species of \u03b2-Amyloid and \u03b1-Synuclein Promote Oligomerization while Inhibiting Fibrillization.","volume":"5","author":"Kim","year":"2020","journal-title":"Biochemistry"},{"key":"31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein","volume":"2","author":"Demuth","year":"2020","journal-title":"Molecules"},{"key":"32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0006-8993(99)01848-x","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies.","volume":"84","author":"Kawai","year":"1999","journal-title":"Brain Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein.","volume":"30","author":"Lee","year":"2003","journal-title":"Science"},{"key":"34","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models.","volume":"2","author":"Sidhu","year":"2009","journal-title":"FASEB J"},{"key":"35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.","volume":"7","author":"Scott","year":"2010","journal-title":"Ann Hum Genet"},{"key":"36","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an \u03b1-synuclein-overexpressing transgenic model of Parkinson\u2019s disease.","volume":"3","author":"Sidhu","year":"2011","journal-title":"Eur J Neurosci"},{"key":"37","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau Interacts with the C-Terminal Region of \u03b1-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.","volume":"5","author":"Lim","year":"2019","journal-title":"Biochemistry"},{"key":"38","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease.","volume":"14","author":"Zhang","year":"2022","journal-title":"Brain"},{"key":"39","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/biomedicines10040760","article-title":"The Role of Tau beyond Alzheimer\u2019s Disease: A Narrative Review.","volume":"1","author":"Comi","year":"2022","journal-title":"Biomedicines"},{"key":"40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging.","volume":"12","author":"Gearing","year":"2014","journal-title":"Acta Neuropathol"},{"key":"41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.","volume":"2","author":"Seilhean","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease.","volume":"36","author":"Buckles","year":"2012","journal-title":"N Engl J Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","article-title":"Longitudinal change in CSF Tau and A\u03b2 biomarkers for up to 48 months in ADNI.","volume":"12","author":"Shaw","year":"2013","journal-title":"Acta Neuropathol"},{"key":"44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons.","volume":"15","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Jellinger. Mild cognitive impairment in Parkinson\u2019s disease: current view. Front Cogn. Frontiers Media SA; 2024; 3. https:\/\/www.frontiersin.org\/journals\/cognition\/articles\/10.3389\/fcogn.2024.1369538\/full.","DOI":"10.3389\/fcogn.2024.1369538"},{"key":"46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/ijms25010498","article-title":"Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.","volume":"2","author":"Jellinger","year":"2023","journal-title":"Int J Mol Sci"},{"key":"47","doi-asserted-by":"publisher","first-page":"943438","DOI":"10.3389\/fnagi.2022.943438","article-title":"Mild cognitive impairment in patients with Parkinson\u2019s disease: An updated mini-review and future outlook.","volume":"1","author":"Wu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mds.27991","article-title":"Neuropathological Findings in Parkinson\u2019s Disease With Mild Cognitive Impairment.","volume":"3","author":"Beach","year":"2020","journal-title":"Mov Disord"},{"key":"49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ana.25239","article-title":"How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder.","volume":"8","author":"Gagnon","year":"2018","journal-title":"Ann Neurol"},{"key":"50","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27135","article-title":"Cognitive changes in prodromal Parkinson's disease: A review.","volume":"3","author":"Kalbe","year":"2017","journal-title":"Mov Disord"},{"key":"51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-024-01758-3","article-title":"Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and A\u03b242 in Alzheimer's disease and other neurodegenerative diseases.","volume":"1","author":"Saito","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"52","doi-asserted-by":"publisher","first-page":"e0171524","DOI":"10.1371\/journal.pone.0171524","article-title":"Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: An autopsy-confirmed study.","volume":"1","author":"Murayama","year":"2017","journal-title":"PLoS One"},{"key":"53","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.","volume":"2","author":"Pani","year":"2024","journal-title":"Alzheimers Dement"},{"key":"54","doi-asserted-by":"publisher","first-page":"e12405","DOI":"10.1002\/dad2.12405","article-title":"Predicting continuous amyloid PET values with CSF and plasma A\u03b242\/A\u03b240.","volume":"1","author":"Fagan","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"key":"55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13195-018-0362-2","article-title":"Addition of the A\u03b242\/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.","volume":"1","author":"Oliveira","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","article-title":"Mixed pathology is more likely in black than white decedents with Alzheimer dementia.","volume":"8","author":"Schneider","year":"2015","journal-title":"Neurology"},{"key":"57","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41531-024-00806-y","article-title":"\u03b1-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease.","volume":"1","author":"Iwata","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"58","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.","volume":"3","author":"Wade-Martins","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"59","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies.","volume":"2","author":"Saiki","year":"2023","journal-title":"Nat Med"},{"key":"60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"quantification of neurofibrillary tangles with [F]MK-6240.","volume":"1","author":"Benedet","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease.","volume":"5","author":"Lees","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"62","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition:DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2202-15-79","article-title":"Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson\u2019s disease.","volume":"1","author":"Kasahara","year":"2014","journal-title":"BMC Neurosci"},{"key":"64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","article-title":"Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.","volume":"4","author":"Charidimou","year":"2018","journal-title":"Stroke"},{"key":"65","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.","volume":"1","author":"Seidl","year":"2004","journal-title":"Mov Disord"},{"key":"66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.sleep.2009.05.007","article-title":"The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version.","volume":"1","author":"Hirata","year":"2009","journal-title":"Sleep Med"},{"key":"67","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/chemse\/bjj042","article-title":"Development of a smell identification test using a novel stick-type odor presentation kit.","volume":"3","author":"Kobayakawa","year":"2006","journal-title":"Chem Senses"},{"key":"68","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.parkreldis.2015.05.001","article-title":"Olfactory function combined with morphology distinguishes Parkinson\u2019s disease.","volume":"2","author":"Iguchi","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"69","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41598-017-05201-7","article-title":"Heterogeneity of odorant identification impairment in patients with Alzheimer\u2019s Disease.","volume":"7","author":"Akishita","year":"2017","journal-title":"Sci Rep"},{"key":"70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00702-023-02611-y","article-title":"Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes.","volume":"13","author":"Iwata","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"key":"71","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","article-title":"Japanese multicenter database of healthy controls for [I]FP-CIT SPECT.","volume":"4","author":"Murakami","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"72","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","article-title":"Autopsy Validation of the Diagnostic Accuracy ofI-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease.","volume":"9","author":"Murayama","year":"2022","journal-title":"Neurology"},{"key":"73","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.2967\/jnumed.114.142794","article-title":"Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.","volume":"4","author":"Nakata","year":"2015","journal-title":"J Nucl Med"},{"key":"74","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12149-016-1065-z","article-title":"Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.","volume":"3","author":"Okuda","year":"2016","journal-title":"Ann Nucl Med"},{"key":"75","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1212\/wnl.54.9.1875","article-title":"Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies.","volume":"5","author":"Yamanouchi","year":"2000","journal-title":"Neurology"},{"key":"76","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1212\/WNL.0000000000201647","article-title":"CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.","volume":"10","author":"Adachi","year":"2023","journal-title":"Neurology"},{"key":"77","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics.","volume":"4","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T14:39:45Z","timestamp":1754491185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":77,"alternative-id":["206297"],"URL":"https:\/\/doi.org\/10.18632\/aging.206297","relation":{},"ISSN":["1945-4589"],"issn-type":[{"type":"electronic","value":"1945-4589"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}